{"id":"https://openalex.org/W1955830815","doi":"https://doi.org/10.1093/toxsci/kfv159","title":"Quantification of Drug-Induced Inhibition of Canalicular Cholyl-l-Lysyl-Fluorescein Excretion From Hepatocytes by High Content Cell Imaging","display_name":"Quantification of Drug-Induced Inhibition of Canalicular Cholyl-l-Lysyl-Fluorescein Excretion From Hepatocytes by High Content Cell Imaging","alternate_titles":[],"publication_year":2015,"publication_date":"2015-07-27","ids":{"openalex":"https://openalex.org/W1955830815","doi":"https://doi.org/10.1093/toxsci/kfv159","mag":"1955830815","pmid":"https://pubmed.ncbi.nlm.nih.gov/26220638"},"language":"en","primary_location":{"id":"doi:10.1093/toxsci/kfv159","doi":"https://doi.org/10.1093/toxsci/kfv159","is_oa":false,"landing_page_url":"https://doi.org/10.1093/toxsci/kfv159","pdf_url":null,"source":{"id":"https://openalex.org/S186282544","display_name":"Toxicological Sciences","issn_l":"1096-0929","issn":["1096-0929","1096-6080"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicological Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1955830815"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112477982","display_name":"Jane Barber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jane A. Barber","raw_affiliation_strings":["*Innovative Medicines & Early Development, Discovery Safety, Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield SK10 4TG, UK; Department of Pharmacology & Therapeutics, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, Merseyside, UK; janehopwood111@gmail.com","*Innovative Medicines & Early Development, Discovery Safety, Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield SK10 4TG, UK;","\u2020Department of Pharmacology & Therapeutics, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, Merseyside, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"*Innovative Medicines & Early Development, Discovery Safety, Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield SK10 4TG, UK; Department of Pharmacology & Therapeutics, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, Merseyside, UK; janehopwood111@gmail.com","institution_ids":["https://openalex.org/I105036370","https://openalex.org/I146655781"]},{"raw_affiliation_string":"*Innovative Medicines & Early Development, Discovery Safety, Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield SK10 4TG, UK;","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"\u2020Department of Pharmacology & Therapeutics, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, Merseyside, UK;","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051498699","display_name":"Simone H. Stahl","orcid":"https://orcid.org/0000-0001-9039-9067","observed_orcids":["https://orcid.org/0000-0001-9039-9067"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Simone H. Stahl","raw_affiliation_strings":["DMPK and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DMPK and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050771546","display_name":"Claire Summers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claire Summers","raw_affiliation_strings":["*Innovative Medicines & Early Development, Discovery Safety, Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield SK10 4TG, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"*Innovative Medicines & Early Development, Discovery Safety, Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield SK10 4TG, UK;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009538553","display_name":"Gillian Barrett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gillian Barrett","raw_affiliation_strings":["Oncology iMEDs, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology iMEDs, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005620651","display_name":"B. Kevin Park","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B. Kevin Park","raw_affiliation_strings":["Department of Pharmacology & Therapeutics, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, Merseyside, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology & Therapeutics, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, Merseyside, UK;","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044365800","display_name":"John Reginald Foster","orcid":"https://orcid.org/0000-0001-9933-1181","observed_orcids":["https://orcid.org/0000-0001-9933-1181"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John R. Foster","raw_affiliation_strings":["*Innovative Medicines & Early Development, Discovery Safety, Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield SK10 4TG, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"*Innovative Medicines & Early Development, Discovery Safety, Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield SK10 4TG, UK;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028281331","display_name":"J. Gerry Kenna","orcid":"https://orcid.org/0000-0002-6927-8962","observed_orcids":["https://orcid.org/0000-0002-6927-8962"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Gerald Kenna","raw_affiliation_strings":["*Innovative Medicines & Early Development, Discovery Safety, Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield SK10 4TG, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"*Innovative Medicines & Early Development, Discovery Safety, Drug Safety & Metabolism, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield SK10 4TG, UK;","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4671,"currency":"USD","value_usd":4671},"apc_paid":null,"fwci":1.9635,"has_fulltext":false,"cited_by_count":45,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.87819957,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"148","issue":"1","first_page":"48","last_page":"59"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-induced-liver-injury","display_name":"drug-induced liver injury","score":0.7760000228881836},{"id":"https://openalex.org/keywords/biliary-excretion","display_name":"biliary excretion","score":0.7990000247955322},{"id":"https://openalex.org/keywords/mrp2","display_name":"MRP2","score":0.8569999933242798},{"id":"https://openalex.org/keywords/bile-salt-export-pump","display_name":"bile salt export pump","score":0.828000009059906},{"id":"https://openalex.org/keywords/taurocholate-uptake","display_name":"taurocholate uptake","score":0.7559999823570251},{"id":"https://openalex.org/keywords/hepatocyte-culture","display_name":"hepatocyte culture","score":0.515999972820282},{"id":"https://openalex.org/keywords/drug-safety-assessment","display_name":"drug safety assessment","score":0.3959999978542328}],"concepts":[{"id":"https://openalex.org/C36201501","wikidata":"https://www.wikidata.org/wiki/Q17907816","display_name":"Multidrug resistance-associated protein 2","level":5,"score":0.9378212690353394},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.7623133659362793},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7167724370956421},{"id":"https://openalex.org/C2910800957","wikidata":"https://www.wikidata.org/wiki/Q15315873","display_name":"Bile Salt Export Pump","level":4,"score":0.6775587797164917},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6240740418434143},{"id":"https://openalex.org/C2776200302","wikidata":"https://www.wikidata.org/wiki/Q827450","display_name":"Hepatocyte","level":3,"score":0.6008751392364502},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4813009798526764},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.46606260538101196},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.4579237401485443},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4148115813732147},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.3638671636581421},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.35865968465805054},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.3538835942745209},{"id":"https://openalex.org/C44312359","wikidata":"https://www.wikidata.org/wiki/Q286958","display_name":"ATP-binding cassette transporter","level":4,"score":0.28696179389953613},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.226173996925354},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000074020","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 11","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000089762","descriptor_name":"Multidrug Resistance-Associated Protein 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001648","descriptor_name":"Bile Canaliculi","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D001648","descriptor_name":"Bile Canaliculi","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001648","descriptor_name":"Bile Canaliculi","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002793","descriptor_name":"Cholic Acids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D005452","descriptor_name":"Fluoresceins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005456","descriptor_name":"Fluorescent Dyes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013656","descriptor_name":"Taurocholic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016764","descriptor_name":"Cell Polarity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018528","descriptor_name":"ATP-Binding Cassette Transporters","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018528","descriptor_name":"ATP-Binding Cassette Transporters","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018528","descriptor_name":"ATP-Binding Cassette Transporters","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D022781","descriptor_name":"Hepatocytes","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D022781","descriptor_name":"Hepatocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D022781","descriptor_name":"Hepatocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D027425","descriptor_name":"ATP-Binding Cassette, Sub-Family C Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D027425","descriptor_name":"ATP-Binding Cassette, Sub-Family C Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D027425","descriptor_name":"ATP-Binding Cassette, Sub-Family C Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D065567","descriptor_name":"Absorption, Physiological","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/toxsci/kfv159","doi":"https://doi.org/10.1093/toxsci/kfv159","is_oa":false,"landing_page_url":"https://doi.org/10.1093/toxsci/kfv159","pdf_url":null,"source":{"id":"https://openalex.org/S186282544","display_name":"Toxicological Sciences","issn_l":"1096-0929","issn":["1096-0929","1096-6080"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicological Sciences","raw_type":"journal-article"},{"id":"pmid:26220638","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26220638","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicological sciences : an official journal of the Society of Toxicology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2100064677","display_name":"Centre for Drug Safety Science (CDSS)","funder_award_id":"MR/L006758/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320322783","display_name":"MedImmune","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W24984958","https://openalex.org/W1486735271","https://openalex.org/W1490154674","https://openalex.org/W1888874925","https://openalex.org/W1977122152","https://openalex.org/W1977536805","https://openalex.org/W1981078602","https://openalex.org/W1981230656","https://openalex.org/W1983060510","https://openalex.org/W1991257654","https://openalex.org/W2006054327","https://openalex.org/W2016714682","https://openalex.org/W2021841041","https://openalex.org/W2023922443","https://openalex.org/W2031073731","https://openalex.org/W2031896095","https://openalex.org/W2034467767","https://openalex.org/W2038011391","https://openalex.org/W2044459219","https://openalex.org/W2048469010","https://openalex.org/W2051965179","https://openalex.org/W2053595725","https://openalex.org/W2053948474","https://openalex.org/W2066495238","https://openalex.org/W2067188612","https://openalex.org/W2098195698","https://openalex.org/W2101528448","https://openalex.org/W2107978273","https://openalex.org/W2110942596","https://openalex.org/W2124428389","https://openalex.org/W2134837921","https://openalex.org/W2138349014","https://openalex.org/W2139570817","https://openalex.org/W2143808974","https://openalex.org/W2144948193","https://openalex.org/W2145394548","https://openalex.org/W2146589346","https://openalex.org/W2146718361","https://openalex.org/W2147909274","https://openalex.org/W2149112832","https://openalex.org/W2152548885","https://openalex.org/W2166939062","https://openalex.org/W2171075953","https://openalex.org/W2302091022","https://openalex.org/W2316475322","https://openalex.org/W2414945378"],"related_works":["https://openalex.org/W1840672957","https://openalex.org/W2985695654","https://openalex.org/W2125150734","https://openalex.org/W2005760784","https://openalex.org/W2004102884","https://openalex.org/W2134837921","https://openalex.org/W3087203104","https://openalex.org/W2171636541","https://openalex.org/W4312186290","https://openalex.org/W2149112832"],"abstract_inverted_index":{"We":[0],"describe":[1],"the":[2,22,92,101,106,114,151,154,163,173,176,182,192,202],"use":[3],"of":[4,21,40,46,67,69,91,103,105,153,172,181,200,240,250],"a":[5,44,64,218,234],"commercially":[6],"available":[7],"high":[8],"content":[9],"cell":[10],"imaging":[11,229],"algorithm":[12],"(Cellomics":[13],"Arrayscan":[14],"Spot":[15],"Detector)":[16],"to":[17,37,116],"quantify":[18],"biliary":[19,58,241],"excretion":[20],"fluorescent":[23],"probe":[24,93],"substrate":[25,94],"cholyl-l-lysyl-fluorescein":[26],"(CLF)":[27],"from":[28,61],"rat":[29],"hepatocytes":[30,62],"cultured":[31],"in":[32,203,210],"collagen/matrigel":[33],"sandwich":[34],"configuration":[35],"and":[36,63,78,169,184,212],"explore":[38],"inhibition":[39,70,104,121,126,141,149,188,215,232,243],"this":[41],"process":[42],"by":[43,136,150,244],"variety":[45],"test":[47],"compounds.":[48],"The":[49,138],"method":[50,237],"provided":[51],"robust,":[52],"reproducible":[53],"data.":[54,127],"Twenty-nine":[55],"pharmaceuticals":[56],"inhibited":[57,84,88],"CLF":[59,85,125,133,139,186,231],"efflux":[60,86,140,187,242],"broad":[65],"range":[66],"potencies":[68,102],"were":[71],"observed":[72],"(IC50":[73],"values":[74,190],"ranged":[75],"between":[76,100,175],"<1":[77],"794":[79],"\u00b5M).":[80],"Thirteen":[81],"drugs":[82,152,165,183],"that":[83,132,162,194,213,228],"also":[87],"hepatocellular":[89],"uptake":[90,119],"[(3)H]-taurocholate.":[95],"Although":[96],"no":[97],"clear":[98],"correlation":[99],"2":[107],"processes":[108],"was":[109],"evident,":[110],"these":[111],"data":[112,142,147,226],"highlight":[113],"need":[115],"consider":[117],"possible":[118],"transporter":[120],"when":[122],"interpreting":[123],"hepatocyte":[124,230],"It":[128],"has":[129],"been":[130],"reported":[131],"is":[134,233],"transported":[135],"MRP2.":[137],"correlated":[143],"closely":[144],"with":[145],"published":[146],"on":[148],"bile":[155],"salt":[156],"export":[157],"pump":[158],"(Bsep),":[159],"which":[160,246],"suggests":[161],"tested":[164],"inhibit":[166],"both":[167],"Bsep":[168],"Mrp2.":[170],"Calculation":[171],"ratios":[174],"maximum":[177],"human":[178],"plasma":[179],"concentrations":[180],"their":[185],"IC50":[189],"raised":[191],"possibility":[193],"for":[195,238],"many,":[196],"but":[197],"not":[198],"all,":[199],"them":[201],"vitro":[204],"effects":[205],"may":[206],"be":[207,217],"functionally":[208],"significant":[209],"vivo":[211],"Mrp2":[214],"might":[216],"drug-induced":[219],"liver":[220],"injury":[221],"(DILI)":[222],"risk":[223],"factor.":[224],"These":[225],"indicate":[227],"promising":[235],"new":[236],"quantification":[239],"drugs,":[245],"could":[247],"aid":[248],"assessment":[249],"compound-related":[251],"DILI":[252],"risk.":[253]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1955830815","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
